<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141312">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01261338</url>
  </required_header>
  <id_info>
    <org_study_id>10100801 1R21ES019206-01</org_study_id>
    <secondary_id>1R21ES019206-01</secondary_id>
    <nct_id>NCT01261338</nct_id>
  </id_info>
  <brief_title>Intervention to Reduce Body Burdens of PCBs in Residents of Anniston, Alabama</brief_title>
  <acronym>PCBs</acronym>
  <official_title>Intervention to Reduce Body Burdens of PCBs in Residents of Anniston, Alabama</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ronald Jandacek</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Because of industrial pollution, a large number of people in Annison, Alabama, have elevated
      body burdens of the class of compounds known as polychlorinated biphenyls (PCBs). There is
      evidence that these compounds are associated with risks to health including diabetes. There
      is also evidence that the consumption of a non-absorbable dietary fat can reduce the level
      of compounds like PCBs. This clinical trial will test the hypothesis that a non-absorbable
      dietary fat can reduce the levels of PCBs in subjects in Anniston.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of change of blood levels of PCBs.</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Body Burden of Potentially Toxic Lipophilic Compounds</condition>
  <arm_group>
    <arm_group_label>olestra</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non-absorbable fat</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>olestra</intervention_name>
    <description>non-absorbable dietary fat</description>
    <arm_group_label>olestra</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elevated blood level of PCBs

        Exclusion Criteria:

          -  Pregnancy

          -  Breast-feeding

          -  Weight-loss medication

          -  Gastrointestinal disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald J Jandacek, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West Anniston Foundation</name>
      <address>
        <city>Anniston</city>
        <state>Alabama</state>
        <zip>36201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>October 22, 2012</lastchanged_date>
  <firstreceived_date>December 14, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Cincinnati</investigator_affiliation>
    <investigator_full_name>Ronald Jandacek</investigator_full_name>
    <investigator_title>Adjunct Professor</investigator_title>
  </responsible_party>
  <keyword>PCBs</keyword>
  <keyword>Olestra</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sucrose polyester</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
